Genotropin and Panic attacks - a phase IV clinical study of FDA data

Summary:

Panic attacks is reported as a side effect among people who take Genotropin (somatropin recombinant), especially for people who are female, 50-59 old, also take Synthroid, and have Hypopituitarism.

The phase IV clinical study analyzes which people have Panic attacks when taking Genotropin. It is created by eHealthMe based on reports of 41,867 people who have side effects when taking Genotropin from the FDA, and is updated regularly.

What is Genotropin?

Genotropin has active ingredients of somatropin recombinant. It is often used in growth hormone deficiency. eHealthMe is studying from 41,924 Genotropin users. Check the latest studies of Genotropin.

What is Panic attacks?

Panic attacks is found to be associated with 2,163 drugs and 2,075 conditions by eHealthMe. Check the latest studies of Panic attacks.

On Jun, 26, 2026

41,867 people reported to have side effects when taking Genotropin.
Among them, 14 people (0.03%) have Panic attacks.

Among these 14 people:

What is the gender of people who have Panic attacks when taking Genotropin? *

female: 85.71 %
male: 14.29 %

What is the age of people who have Panic attacks when taking Genotropin? *

What are other drugs people take besides Genotropin? *

What are other side effects people have besides Panic attacks? *

Confusional State: 7 people, 50.00%
Fatigue (feeling of tiredness): 7 people, 50.00%
Headache (pain in head): 6 people, 42.86%
Malaise (a feeling of general discomfort or uneasiness): 6 people, 42.86%
Peripheral Swelling: 6 people, 42.86%
Drowsiness: 6 people, 42.86%
Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle): 4 people, 28.57%
Haemorrhage (bleeding): 2 people, 14.29%
Insomnia (sleeplessness): 2 people, 14.29%
Wound: 2 people, 14.29%

What are the existing conditions these people have? *

Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 6 people, 42.86%
Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 6 people, 42.86%
Sleep Disorder: 1 person, 7.14%
Muscle Tightness: 1 person, 7.14%
Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 1 person, 7.14%
Fatigue (feeling of tiredness): 1 person, 7.14%
Empty Sella Syndrome (pituitary gland shrinks or becomes flattened): 1 person, 7.14%
Dizziness: 1 person, 7.14%
Depression: 1 person, 7.14%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Genotropin and have Panic attacks?

- Check whether Panic attacks is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Genotropin:

Genotropin (41,924 reports)

Panic attacks treatments and more:

Panic attacks (65,704 reports)

Browse all side effects of Genotropin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Panic attacks:

Panic attacks (2,163 drugs)

Browse all the conditions that are associated with Panic attacks:

Panic attacks (2,075 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on somatropin recombinant (the active ingredients of Genotropin) and Genotropin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.